OTC - ACTIVE INGREDIENT SECTION
SODIUM HYALURONATE
SODIUM HYALURONATE
Trehalose
Propanediol
Calendula Officinalis Flower Extract
Panthenol
Glycerin
Butylene Glycol
Caprylyl Glycol
Madecassoside
Salicylic Acid
1,2-Hexanediol
Ethylhexylglycerin
acne patch
Keep out of reach of the children
1. After cleansing, keep your skin clearly.
2. Carefully remove dots from the film.
3. Stick the patch to target areas of concern and gently press down on the patch for 2-3 minutes.
4. Leave in place for 2 hours or more.(Use it during the day or night)
1. Do not use in the following cases(Eczema and scalp wounds)
2.Side Effects
1)Due to the use of this druf if rash, irritation, itching and symptopms of hypersnesitivity occur dicontinue use and consult your phamacisr or doctor
3.General Precautions
1)If in contact with the eyes, wash out thoroughty with water If the symptoms are servere, seek medical advice immediately
2)This product is for exeternal use only. Do not use for internal use
4.Storage and handling precautions
1)If possible, avoid direct sunlight and store in cool and area of low humidity
2)In order to maintain the quality of the product and avoid misuse
3)Avoid placing the product near fire and store out in reach of children
for external use only
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71184-0002-1 | 2023-09-06 | C162847 | 48780-1 | d6a99b39-a63a-a426-e053-dadaa90af4c2 | a5d685bb-7141-44c5-e053-2995a90a1d3d |
| 71184-0002-1 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-a63a-a426-e053-dadaa90af4c2 | a5d685bb-7141-44c5-e053-2995a90a1d3d |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 71184-0002 | 71184-0002-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| HYALURONATE SODIUM | YSE9PPT4TH | ACTIB |
| WATER | 059QF0KO0R | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 04ab4bc8-af70-711c-e063-6294a90ac13e | a5d685bb-7141-44c5-e053-2995a90a1d3d | 2023-09-06 | Warnings | 04ab4bc8-af70-711c-e063-6294a90ac13e a5d685bb-7141-44c5-e053-2995a90a1d3d |
Adverse event summaries are temporarily unavailable. Other product information remains available.